Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$592M |
| 2 |
Advanced Micro Devices
AMD
|
+$510M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$427M |
| 4 |
Paychex
PAYX
|
+$383M |
| 5 |
MetLife
MET
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.18B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$576M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$564M |
| 4 |
Apple
AAPL
|
+$555M |
| 5 |
JPMorgan Chase
JPM
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.21% |
| 2 | Healthcare | 13.42% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $9.73M | ﹤0.01% |
146,213
+10,673
| +8% | +$724K |
|
|
EBIX
2077
DELISTED
Ebix Inc
EBIX
| $9.73M | ﹤0.01% |
293,457
+1,350
| +0.5% | +$42.2K |
|
|
NSTG
2078
DELISTED
NanoString Technologies, Inc.
NSTG
| $9.72M | ﹤0.01% |
279,646
-7,198
| -3% | -$248K |
|
|
ENFN
2079
DELISTED
Enfusion, Inc.
ENFN
| $9.7M | ﹤0.01% |
762,883
+713,201
| +1,436% | +$10.9M |
|
2080
CEVA Inc
CEVA
$937M
| $9.7M | ﹤0.01% |
238,601
-758
| -0.3% | -$29.5K |
|
2081
Movado Group
MOV
$803M
| $9.69M | ﹤0.01% |
248,167
-19,332
| -7% | -$733K |
|
|
LGO
2082
Largo
LGO
$74.1M
| $9.68M | ﹤0.01% |
761,826
-29,667
| -4% | -$307K |
|
2083
Genesco
GCO
$391M
| $9.66M | ﹤0.01% |
151,925
-3,480
| -2% | -$226K |
|
2084
Nektar Therapeutics
NKTR
$2.49B
| $9.65M | ﹤0.01% |
119,383
+5,870
| +5% | +$869K |
|
|
OPTU
2085
Optimum Communications Inc
OPTU
$251M
| $9.62M | ﹤0.01% |
771,039
+37,677
| +5% | +$503K |
|
2086
Riskified
RSKD
$875M
| $9.59M | ﹤0.01% |
+1,587,249
| New | +$10.6M |
|
2087
Core Laboratories
CLB
$571M
| $9.58M | ﹤0.01% |
302,962
-1,467
| -0.5% | -$41.1K |
|
2088
Frontdoor
FTDR
$5.96B
| $9.58M | ﹤0.01% |
320,874
-36,943
| -10% | -$1.23M |
|
2089
CryoPort
CYRX
$772M
| $9.57M | ﹤0.01% |
274,153
-23,192
| -8% | -$877K |
|
2090
Usana Health Sciences
USNA
$247M
| $9.49M | ﹤0.01% |
119,476
-81
| -0.1% | -$7.3K |
|
2091
ProShares Large Cap Core Plus
CSM
$537M
| $9.49M | ﹤0.01% |
176,333
-14,709
| -8% | -$778K |
|
2092
Enterprise Products Partners
EPD
$84B
| $9.48M | ﹤0.01% |
367,471
-15,959
| -4% | -$387K |
|
|
OLO
2093
DELISTED
Olo Inc
OLO
| $9.46M | ﹤0.01% |
713,763
+685,983
| +2,469% | +$10.6M |
|
|
GBT
2094
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.44M | ﹤0.01% |
272,603
+876
| +0.3% | +$26.2K |
|
2095
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $9.42M | ﹤0.01% |
187,301
+6,615
| +4% | +$333K |
|
2096
Stride
LRN
$3.46B
| $9.41M | ﹤0.01% |
259,026
+588
| +0.2% | +$19.5K |
|
2097
Lazard
LAZ
$4.35B
| $9.39M | ﹤0.01% |
272,149
-2,027
| -0.7% | -$78.4K |
|
2098
OceanFirst Financial
OCFC
$1.91B
| $9.32M | ﹤0.01% |
463,603
-6,632
| -1% | -$148K |
|
2099
Madison Square Garden
MSGS
$9.8B
| $9.31M | ﹤0.01% |
51,895
-4,995
| -9% | -$851K |
|
2100
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $9.3M | ﹤0.01% |
197,460
-35,045
| -15% | -$1.62M |
|
Similar funds
Bank of New York Mellon's Q1 2022 Portfolio in Review
As of Q1 2022, Bank of New York Mellon held 4,798 positions worth $516B, down 6.9% from $554B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q1 2022 filing shows 182 new, 1,981 increased, 2,086 reduced and 146 closed positions. Its largest new stake was Constellation Energy: 6,682,470 shares worth $376M. The largest sale was Oracle, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2022 buy was Constellation Energy: 6,682,470 shares worth $376M.
- Bank of New York Mellon added most to S&P Global in Q1 2022, an estimated $592M increase.
- Bank of New York Mellon's biggest Q1 2022 reduction was Oracle, cutting an estimated $1.18B.
- Bank of New York Mellon fully exited Xilinx Inc in Q1 2022, selling an estimated $576M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $516B portfolio in Q1 2022.
- Bank of New York Mellon opened 182 new positions and closed 146 in Q1 2022.
- Bank of New York Mellon's portfolio value fell 6.9% quarter-over-quarter to $516B.
Based on Bank of New York Mellon's 13F filing for Q1 2022, filed 11 May 2022.